Censored patients in Kaplan–Meier plots of cancer drugs: An empirical analysis of data sharing
Open Access
- 1 December 2020
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 141, 152-161
Abstract
No abstract availableKeywords
Funding Information
- Oregon Health and Science University
- Arnold Ventures
This publication has 38 references indexed in Scilit:
- Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trialThe Lancet Oncology, 2018
- Once weekly versus twice weekly carfilzomib dosing in patients with relapsed and refractory multiple myeloma (A.R.R.O.W.): interim analysis results of a randomised, phase 3 studyThe Lancet Oncology, 2018
- Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trialThe Lancet Oncology, 2018
- NGR-hTNF in combination with best investigator choice in previously treated malignant pleural mesothelioma (NGR015): a randomised, double-blind, placebo-controlled phase 3 trialThe Lancet Oncology, 2018
- The role of censoring on progression free survival: Oncologist discretion advisedEuropean Journal of Cancer, 2015
- Influence of censoring on conclusions of trials for women with metastatic breast cancerEuropean Journal of Cancer, 2015
- The Clinical Viewpoint: Definitions, Limitations of RECIST, Practical Considerations of MeasurementClinical Cancer Research, 2013
- Randomized controlled trials in the era of molecular oncology: methodology, biomarkers, and end pointsAnnals of Oncology, 2011
- Alternative End Points to Evaluate a Therapeutic Strategy in Advanced Colorectal Cancer: Evaluation of Progression-Free Survival, Duration of Disease Control, and Time to Failure of Strategy—An Aide et Recherche en Cancérologie Digestive Group StudyJournal of Clinical Oncology, 2011
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesThe Lancet, 2007